Last deal

$41.95M

Amount

Series E

Stage

03.03.2014

Date

3

all rounds

$164.44M

Total amount

date founded

Financing round

General

About Company
RainDance Technologies develops products to improve disease detection in human healthcare.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Series E

IPO status

Private

Description

RainDance Technologies, based in Lexington, Massachusetts, supports customers through international sales and service operations and a global network of distributors and service providers. In January 2017, the company was acquired by Bio Rad. Their ultra-sensitive genomic tools enable research of non-invasive liquid biopsy applications, leading to better detection of cancer and other diseases. Major research institutions and laboratories rely on RainDance systems, which have been recognized as top innovations in the field.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
PrognomiQ

PrognomiQ

PrognomiQ is a biotech firm that develops test products for early disease detection through the power of multi-omics data.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Mateo, CA, USA

total rounds

2

total raised

$101M
PhageTech

PhageTech

PhageTech develops bio conducting materials that revolutionize disease detection.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Irvine, CA, USA

total rounds

4

total raised

$12.4M
Mursla

Mursla

Mursla is a multi-omics exosome characterisation company that detects the tissue-specific exosomes in blood for biomedical applications.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Cambridge, UK

total rounds

4

total raised

$7.25M
Aperiomics

Aperiomics

Aperiomics is revolutionizing infection testing for improved global health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sterling, VA, USA

total rounds

6

total raised

$5.2M
M&A Details
1

Acquired by

Bio-Rad Laboratories

announced date

16.01.2017

price

$87M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$164.44M

Money Raised

Their latest funding was raised on 03.03.2014. Their latest investor Acadia Woods Partners. Their latest round Series E

Date 
Funding Round 
Investors 
Money Raised 
Lead 
22.09.2013
1
$35M
29.04.2013
6
$20.33M
Northgate Capital

Northgate Capital

Global venture capital and private equity firm investing in early and later stage companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Software, Analytics

Location

Danville, CA, USA

count Of Investments

97

count Of Exists

45
GE Ventures

GE Ventures

GE Ventures helps startups accelerate growth through expertise and resources.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Business Development, Consulting

Location

Menlo Park, CA, USA

count Of Investments

122

count Of Exists

37
CRG

CRG

CRG is a healthcare-focused investment firm that provides customized financing solutions.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Houston, TX, USA

count Of Investments

56

count Of Exists

16
Myriad Genetics

Myriad Genetics

Myriad Genetics is a personalized medicine company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Therapeutics

Location

Salt Lake City, UT, USA

total rounds

1

total raised

$90M

count Of Investments

1

count Of Exists

1
Co-Investors
Investors
9
5

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
Acadia Woods Partners

Acadia Woods Partners

Acadia Woods Partners is an early-stage technology investment partnership based in New York.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

46

count Of Exists

14
Jeff Samberg

Jeff Samberg

Jeff Samberg is the Managing Member of Acadia Woods Partners, LLC, a New York-based investment partnership that focuses primarily on early-stage technology companies. He lived in the San Francisco Bay area for 15 years where he held a number of high-technology management roles, including Vice President of Corporate Strategy for PeopleSoft Inc., Vice President of Business Development for Wily Technology, and Entrepreneur in Residence for Greylock Partners. Mr. Samberg received his MBA from Stanford University’s Graduate School of Business and his B.A. with high honors in economics from Princeton University.

current job

Acadia Woods Partners
Acadia Woods Partners

count Of Investments

3

count Of Exists

1
Mohr Davidow Ventures

Mohr Davidow Ventures

Mohr Davidow Ventures invests in early-stage technology startups to create new markets.

Sector

General Industrials

Subsector

Diversified Industrials

Location

San Mateo, CA, USA

count Of Investments

240

count Of Exists

79
Bill Ericson

Bill Ericson

Bill Ericson is a Founding Partner at Wildcat where he focuses on investments in artificial intelligence (AI), machine learning (ML) and enterprise software as a service (SaaS) as enablers of digital health, vertical apps, and enterprise and consumer communications. His specific areas of interest include improving the digital health ecosystem to deliver better, more efficient, healthcare, and the role data and machine intelligence can play in virtualizing processes in the healthcare market. Concurrently, he is a Managing Partner of Mohr Davidow Ventures, where he started his venture career. The son of a Foreign Service officer, Bill grew up as a citizen of the world, living in England, Iceland, Korea and Japan, and learned to speak Japanese. Bill’s career role model is Bill Davidow, founder of Mohr Davidow Ventures, for his extraordinary humanity and remarkable business insights. In his spare time, Bill can be found playing electric guitar (wishing he could play like Derek Trucks), and cheering on the Golden State Warriors. Bill has worked with technology entrepreneurs for his entire career, which spans more than two decades. Trained in economics and law, Bill is keenly interested in how technology, social media and big data is transforming society and human interactions. In this light, Bill has contributed to a new curriculum on digital ethics for the Kennedy School of Ethics at his alma mater, Georgetown University. A former attorney, he was an early partner and founder of the Seattle office of Venture Law Group before joining Mohr Davidow Ventures, where he began his venture capital career. Bill received his B.S.F.S. from Georgetown University School of Foreign Service and a J.D. from Northwestern University School of Law.

current job

Wildcat Venture Partners
Wildcat Venture Partners
Myriad Genetics

Myriad Genetics

Myriad Genetics is a personalized medicine company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Therapeutics

Location

Salt Lake City, UT, USA

total rounds

1

total raised

$90M

count Of Investments

1

count Of Exists

1

People

Founders
5
Darren Link
Darren Link

Darren Link

Darren Link is the VP R&D Digital Biology Group at Bio-Rad Laboratories

current job

Bio-Rad Laboratories
Bio-Rad Laboratories

organization founded

1

Darren Link

David Weitz

current job

RainDance Technologies
RainDance Technologies

David Weitz

Jerome Bibette

current job

RainDance Technologies
RainDance Technologies

Jerome Bibette

Jonathan M. Rothberg
Jonathan M. Rothberg

Jonathan M. Rothberg

Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.

current job

Butterfly Network
Butterfly Network

count Of Investments

1

Jonathan M. Rothberg

Employee Profiles
50

James Hartigan

Commercial applications scientist

Roch Kelly

Roch Kelly

Sr. VP Operations

Jerome Bibette

Founder

Kathy Ordoñez

CEO

David Weitz

CTO

Yafei Liu

Yafei Liu

VP, Commercial Operation

Andrew Griffiths

Founder

Jonathan M. Rothberg

Jonathan M. Rothberg

Co-Founder

Activity

Recent News
0